These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8471337)

  • 1. Economic evaluation and quality of life assessments in cancer clinical trials: the CHART Trial.
    Morris J; Goddard M
    Eur J Cancer; 1993; 29A(5):766-70. PubMed ID: 8471337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of quality of life in clinical trials of the British Medical Research Council.
    Machin D
    J Natl Cancer Inst Monogr; 1996; (20):97-102. PubMed ID: 8750478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economic evaluation of the FIRST study: design of a prospective analysis alongside a multinational phase III clinical trial. Flolan International Randomized Survival Trial.
    Schulman KA; Glick H; Buxton M; Sculpher M; Backhouse M; Bell L; Eisenberg JM
    Control Clin Trials; 1996 Aug; 17(4):304-15. PubMed ID: 8889345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life assessment in International Breast Cancer Study Group (IBCSG) trials: practical issues and factors associated with missing data.
    Bernhard J; Peterson HF; Coates AS; Gusset H; Isley M; Hinkle R; Gelber RD; Castiglione-Gertsch M; Hürny C
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):587-601. PubMed ID: 9549808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation.
    Picot J; Copley V; Colquitt JL; Kalita N; Hartwell D; Bryant J
    Health Technol Assess; 2015 Aug; 19(69):1-190. PubMed ID: 26323045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation Therapy Oncology Group (RTOG).
    Wasserman T; Bruner D; Scott C
    J Natl Cancer Inst Monogr; 1996; (20):81-2. PubMed ID: 8750473
    [No Abstract]   [Full Text] [Related]  

  • 7. Trial-related quality of life: using quality-of-life assessment to distinguish among cancer therapies.
    Gotay CC
    J Natl Cancer Inst Monogr; 1996; (20):1-6. PubMed ID: 8750459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality-of-life studies of the National Cancer Institute of Canada Clinical Trials Group.
    Osoba D; Dancey J; Zee B; Myles J; Pater J
    J Natl Cancer Inst Monogr; 1996; (20):107-11. PubMed ID: 8750480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality-of-life research in the Pediatric Oncology Group: 1991-1995.
    Bradlyn AS; Pollock BH
    J Natl Cancer Inst Monogr; 1996; (20):49-53. PubMed ID: 8750466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life in clinical cancer trials: experience and perspective of the European Organization for Research and Treatment of Cancer.
    Kiebert GM; Kaasa S
    J Natl Cancer Inst Monogr; 1996; (20):91-5. PubMed ID: 8750477
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiation Therapy Oncology Group quality of life assessment: design, analysis, and data management issues.
    Scott CB; Stetz J; Bruner DW; Wasserman TH
    Qual Life Res; 1994 Jun; 3(3):199-206. PubMed ID: 7920494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recruiting long-term survivors of European Organisation for Research and Treatment of Cancer phase III clinical trials into quality of life studies: challenges and opportunities.
    van Leeuwen M; Efficace F; Fosså SD; Bolla M; De Giorgi U; de Wit R; Holzner B; van de Poll-Franse LV; van Poppel H; White J; Collette L; Osanto S; Aaronson NK; ; ;
    Eur J Cancer; 2014 Jul; 50(11):1957-63. PubMed ID: 24820932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. United Kingdom Cancer Research Campaign approach to quality-of-life research in cancer clinical trials.
    Hopwood P
    J Natl Cancer Inst Monogr; 1996; (20):103-5. PubMed ID: 8750479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free-riding and the prisoner's dilemma: problems in funding economic analyses of phase III cancer clinical trials.
    Bennett CL; Smith TJ; George SL; Hillner BE; Fleishman S; Niell HB
    J Clin Oncol; 1995 Sep; 13(9):2457-63. PubMed ID: 7545222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frailty models for quality of life in oncology.
    Troxel AB; Esserman DA
    J Biopharm Stat; 2004 Feb; 14(1):145-54. PubMed ID: 15027505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Sufficient life expectancy": an amazing inclusion criterion in cancer phase II-III trials.
    Penel N; Clisant S; Lefebvre JL; Adenis A
    J Clin Oncol; 2009 Sep; 27(26):e105. PubMed ID: 19667257
    [No Abstract]   [Full Text] [Related]  

  • 17. Economic analysis in phase III clinical cancer trials.
    Bennett CL; Armitage JL; Buchner D; Gulati S
    Cancer Invest; 1994; 12(3):336-42. PubMed ID: 8187012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An approach to the design and implementation of clinical trials of empirical antibiotic therapy in febrile and neutropenic cancer patients.
    Viscoli C; Bruzzi P; Glauser M
    Eur J Cancer; 1995 Nov; 31A(12):2013-22. PubMed ID: 8562158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Added value of health-related quality of life measurement in cancer clinical trials: the experience of the NCIC CTG.
    Au HJ; Ringash J; Brundage M; Palmer M; Richardson H; Meyer RM;
    Expert Rev Pharmacoecon Outcomes Res; 2010 Apr; 10(2):119-28. PubMed ID: 20384559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical design issues and other practical considerations for conducting phase III prostate cancer prevention trials.
    Tangen CM; Goodman PJ; Crowley JJ; Thompson IM
    J Urol; 2004 Feb; 171(2 Pt 2):S64-7. PubMed ID: 14713757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.